News Break! Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Break! Middle East.

Press releases published on October 28, 2026

Oct. 28, 2026

Sofwave to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

UroGen’s Final Results from Olympus Five-Year Follow-Up Study Reinforces Durable Response with JELMYTO in Patients with Low-Grade Upper Tract Urothelial Cancer

Indeterminate GlobeNewswire

Oct. 28, 2026

ORYZON to participate in upcoming events in November

Indeterminate GlobeNewswire

Oct. 28, 2026

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 

Indeterminate GlobeNewswire

Oct. 28, 2026

Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire

Oct. 28, 2026

PolyPid Unveils Expanded Pipeline Strategy, Introducing PD01B, a New Kynatrix™ Based Product Candidate for the Treatment of Diabetic Foot Infections

Indeterminate GlobeNewswire

Oct. 28, 2026

ODDITY to Announce Third Quarter 2026 Financial Results on November 11, 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

Aventis Energy Enters into Option Agreement to Acquire the Past-Producing Seneca VMS Project in Southwestern British Columbia

Indeterminate GlobeNewswire

Oct. 28, 2026

Atico Continues to Extend the Ore Body at El Roble Mine in Colombia and Reports Multiple Higher-Grade Intercepts up to 18.6m of 7.65% Cu, 2.22 g/t Au, 9.0m of 8.44% Cu, 3.58 g/t Au and 5.7m of 8.48% Cu, 7.41 g/t Au

Indeterminate GlobeNewswire

Oct. 28, 2026

Micron Biomedical Appoints Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product Commercialization

Indeterminate GlobeNewswire

Oct. 28, 2026

Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Oct. 28, 2026

BPGbio Publishes Pioneering Research on Novel Brain-Penetrant Therapeutic Candidate for Glioma

Indeterminate GlobeNewswire

Oct. 28, 2026

Newcore Gold Drilling Intersects 2.16 g/t Gold over 37.0 Metres, Including 5.10 g/t Gold over 9.0 Metres, at the Enchi Gold Project, Ghana

Indeterminate GlobeNewswire

Oct. 28, 2026

Rapport Announces Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement

Indeterminate GlobeNewswire

Oct. 28, 2026

Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program

Indeterminate GlobeNewswire

Oct. 28, 2026

B2PRIME Brings Market Intelligence to Claude, Advancing its AI-Native Brokerage Strategy

Indeterminate GlobeNewswire

Oct. 28, 2026

Nxera Pharma Secures Exclusive Rights to Fabry Disease Phase 3 Oral Therapy Candidate Lucerastat for Japan and Selected Asia Pacific Markets

Indeterminate GlobeNewswire

Oct. 28, 2026

Newsweek Places KFSH in Top 4% of World's Smart Hospitals for Digital Maturity and AI

Indeterminate GlobeNewswire